Influence of spironolactone therapy on thiamine blood levels in patients with heart failure;Influência da terapia com espironolactona sobre níveis sangüíneos de tiamina em pacientes com insuficiência cardíaca

Arquivos Brasileiros de Cardiologia

Volumn 90, Issue 5, 2008, Pages

  Rocha, Ricardo Mourilhe ^a,c   Silva, Guilherme Vianna ^b   De Albuquerque, Denilson Campos ^a   Tura, Bernardo Rangel ^a   Albanesi Filho, Francisco Manes ^a  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE   (Brazil)

Author keywords

Cardiac output, low; Spironolactone therapeutic use; Thiamine blood

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SPIRONOLACTONE; THIAMINE; TRANSKETOLASE;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DOSE RESPONSE; DRUG MEGADOSE; DYSLIPIDEMIA; ENZYME ACTIVATION; FEMALE; FOOD INTAKE; HEART FAILURE; HUMAN; HYPERTENSION; MALE; SMOKING; STUDENT T TEST; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALDOSTERONE ANTAGONISTS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIURETICS; EATING; ERYTHROCYTES; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; SPIRONOLACTONE; STATISTICS, NONPARAMETRIC; THIAMINE; THIAMINE DEFICIENCY; TRANSKETOLASE;

EID: 44849098476     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008000500009     Document Type: Article

References (30)

1. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, et al. The epidemiology of heart failure. Eur Heart J. 1997; 18 (2): 208-25.
2. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns and opportunities. N Engl J Med. 1997;337(19):1360-9.
3. Brown AM, Cleland JG. Influence of concomitant disease on patterns of hospitalizations in patients with heart failure from Scottish hospitals in 1995. Eur Heart J. 1998; 19 (7): 1063-9.
4. Barr CS, Lang CC, Hanson J, Arnott M, Kennedy N, Struthers AD. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1995; 76 (17): 1259-65.
5. Farquharson CA, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation. 2000; 101 (6): 594-7.
6. Zucker IH, Wang W, Brandle M, Schultz HD, Patel KP. Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovasc Dis. 1995; 37 (6): 397-414.
7. Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol. 1995; 269 (4 Pt 1): E657-62.
8. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest. 1994; 93 (6): 2578-83.
9. Weber KT. Angiotensin II and connective tissue: homeostasis and reciprocal regulation. Regul Pept. 1999; 82 (1-3): 1-17.
10. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation. 1997; 96 (11): 4065-82.
11. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341 (10): 709-17.
12. Yui Y, Itokawa Y, Kawai C. Furosemide induced thiamine deficiency. Cardiovasc Res. 1980; 14 (9): 537-40.
13. Capelli V, Bottinelli R, Polla B, Reggiani C. Altered contractile properties of rat cardiac muscle during experimental thiamine deficiency and food deprivation. J Mol Cell Cardiol. 1990; 22 (10): 1095-106.
14. Seligmann H, Halkin H, Rauchfleisch S, Kaufmann N, Motro M, Vered Z, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med. 1991; 91 (2): 151-5.
15. Lip GY, Gibbs CR, Beevers DG. ABC of heart failure: aetiology. BMJ. 2000; 320 (7227): 104-7.
16. Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol. 2001; 37 (7): 1765-74.
17. o FM. Espoliação por tiamina com o uso de diuréticos na cardiomiopatia dilatada. Arq Bras Cardiol. 2000; 74 (supl. 1): 80.
18. Brin M. Functional evaluation of nutritional status: thiamin. In: Albanese AA, ed. Newer methods of nutritional biochemistry. New York: Academic Press; 1967. p. 407-45.
19. Schouten H, Statiusvaneps LW, Struykerboudier AM. Transketolase in blood. Clin Chim Acta. 1964; 10: 474-6.
20. Fidanza F. Vitamin nutritive methodology. In: Nutritional status assessment: a manual for population studies. London: Chapman & Hall; 1991. p. 228-43.
21. Katz AM, Katz PB. Diseases of the heart in works of Hippocrates. Br Heart J. 1962; 24: 257-64.
22. Anker S, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as an independent risk factor for mortality in chronic heart failure. Lancet. 1997; 349 (9058): 1050-3.
23. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990.
24. Cunha S, Albanesi Filho FM, Bastos VLFC, Antelo DS, Souza MM. Thiamin, selenium, and copper levels in patients with idiopathic dilated cardiomyopathy taking diuretics. Arq Bras Cardiol. 2002; 79 (5): 460-5.
25. Shimon I, Almog S, Vered Z, Seligmann H, Shefi M, Peleg E, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med. 1995; 98 (5): 485-90.
26. Rindi G, Laforenza U. Thiamine intestinal transport and related issues: recent aspects. Proc Soc Exp Biol Med. 2000; 224 (4): 246-55.
27. Gastaldi G, Cova E, Verri A, Laforenza U, Faelli A, Rindi G Transport of thiamin in rat renal brush border membrane vesicles. Kidney Int. 2000; 57 (5): 2043-54.
28. Horisberger JD, Rossier BC. Aldosterone regulation of gene transcription leading to control of ion transport. Hypertension. 1992; 19 (3): 221-7.
29. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension. 1995; 25 (1): 117-23.
30. Wang W, McClain JM, Zucker IH. Aldosterone reduces baroreceptor discharge in the dog. Hypertension. 1992; 19 (3): 270-7.